arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

BELITE BIO, INC

BLTE
$162.65 ▲ +1.50 (+0.93%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
7 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
23
Health
Poor
Neutral
auto_awesome

Analytical Summary

BELITE BIO, INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC
FCF / Share
Trailing P/E
Price / Book 8.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

Health Breakdown

Returns
34
Financial Health
0
Cash Quality
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 7 quarters